| Model Number |
BG101-350 |
| Medical Device Problem Code |
Appropriate Device Problem Term/Code Not Available (3191)
|
| Health Effect - Clinical Codes |
Hyphema (1911); Blurred Vision (2137)
|
| Date of Event |
01/25/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Section a4: unknown/ not provided.Asku.Section d6b: if explanted, give date: not applicable, as no indication that shunt was explanted.Section e1: phone number: unknown/ not provided.Section h3- no: the device was not returned for evaluation, as product remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Section h6: device code: 3191 (to capture unspecified/other w/ patient involvement).Attempts were made to obtain missing information; however, the information was not provided.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
| |
|
Event or Problem Description
|
|
It was reported in a retrospective unmasked study done that a glaucoma shunt was implanted in a patient's left eye due to pre-existing glaucoma.It was learned that one day after implantation of the shunt, hyphema was diagnosed and reported by the site to be a device and procedure related (baerveldt glaucoma shunt surgery).The subject also complained of blurry vision for 1 week visit.Site did not mention any medication but hyphema can recover by itself by letting the patient rest.No change in intraocular pressure (iop) due to hyphema.The shunt remains implanted.No exchange.There was no delay in procedure and no incision enlargement, no vitrectomy, and no sutures done.No other adverse events.Subject fully recovered from hyphema and blurred vision within 36 days, iop is stabilized without sequelae.The intraocular pressure preop: 25 mmhg; 1 day postop: 3mmhg; 1 week postop: 6 mmhg; 6 month postop: 13 mmhg; 12 month postop: 12 mmhg.No other information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrected data: upon further review it was noted that some information was incorrectly provided during the initial report submitted.The correct implant date was (b)(6) 2023 instead of (b)(6) 2023 and date of event was jan.25, 2023 instead of jan.24, 2023.This follow up mdr is submitted to correct information.Fields below are updated.Section b3: date of event: jan.25, 2023.Section d6a: implant date: (b)(6) 2023.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: additional information indicated that this is not a masked clinical study.That this is a retrospective data collection study, collecting data from 1 to 2 years ago.No surgical interventions have been required.It is unknown if medication outside the standard of care were prescribed to the patient.The device remains implanted and the patient has fully recovered.Corrected data: the following fields were updated/corrected based on the additional information received: section e1: initial reporter last name: (b)(6).Section e1: initial reporter e-mail: (b)(6).Section e1:establishment name: (b)(6).Section e1: phone number: (b)(6).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
| |
|
Search Alerts/Recalls
|